Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer
NCT00154700
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
Paclitaxel,Cisplatin,5-Fu,Folic Acid
Sponsor
National Taiwan University Hospital